The one-hour webinar will be held at 2:00 p.m. Eastern Daylight Time on Tuesday, May 5, and will explore the industry’s ...

Originally developed for Type 2 diabetes, glucagon-like peptide-1 (GLP-1) receptor agonists have transformed the weight-loss medication market. And in recent years, their popularity has soared due to ...

This innovative compound is known as a 'quintuple agonist' because it combines the power of GLP-1 and glucose-dependent ...

Experts describe the development of oral GLP-1 medication as a “pivotal” improvement in the accessibility and adherence to obesity drugs. As of February 2026, only Wegovy and Rybelsus are available in ...

From weight loss injections to a newly approved pill, GLP-1 medications are everywhere– but many people are still unclear on who they’re actually for, how they work, and whether newer trends like ...

There is no shortage of headlines about GLP-1 medications. Originally developed to manage blood sugar levels, these medications are now widely known for promoting weight loss. Alongside their rapid ...

Medicare currently covers GLP-1s to treat conditions like Type 2 diabetes. It will begin covering the drug for weight loss with prior authorization beginning in July 2026. It'll be up to Part D plan ...

GLP-1 medications, such as Ozempic and Wegovy, are injected into the fatty layer beneath the skin to manage blood sugar and aid in weight management. The recommended injection sites include the ...

Common GLP-1s include semaglutides like Ozempic and Wegovy, and tirzepatides like Zepbound and Mounjaro. These drugs work by mimicking a natural hormone to regulate appetite, blood sugar, and feelings ...

GLP-1 drugs are meant to treat metabolic diseases like diabetes and obesity. But as they become more available, some people might choose to use them even if they're not currently overweight. NPR's ...